Hemospermia following transrectal ultrasound-guided prostate biopsy: a prospective study.
Hemospermia is known to be associated with transrectal ultrasound-guided prostate biopsy (TRUS-PB). The true incidence of hemospermia, its duration and implications are not well established. We performed a prospective observational study involving patients undergoing TRUS-PB for suspected prostate cancer at our institution. Sixty-three eligible men were included in the study. Most men (84%) undergoing TRUS-PB, who were able to ejaculate, experienced hemospermia, which was associated with some degree of anxiety. The mean duration of hemospermia was 3.5 (+/-1.7) weeks. The number of ejaculations before the complete resolution of hemospermia was 8 (+/-6.7). None of the clinical and pathological factors was a significant predictor of the duration of hemospermia. Patients should be adequately counseled before TRUS-PB to avoid undue anxiety and alterations in sexual activity.
Manoharan
M
M
Department of Urology, University of Miami Miller School of Medicine, Miami, FL 33101, USA. mmanoharan@med.miami.edu
Ayyathurai
R
R
Nieder
A M
AM
Soloway
M S
MS
D001706:Biopsy / Q000009:adverse effects*; D051516:Hemospermia / Q000209:etiology*; D006801:Humans; D008297:Male; D011183:Postoperative Complications; D011471:Prostatic Neoplasms / Q000601:surgery*; D014463:Ultrasonography; D013521:Urologic Surgical Procedures, Male / Q000009:adverse effects*